U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Regulatory Information
  3. Search for FDA Guidance Documents
  4. CPG Sec. 460.425 Prescription Status when Telephoned to Recording Machine
  1. Search for FDA Guidance Documents

COMPLIANCE POLICY GUIDE (CPG)

CPG Sec. 460.425 Prescription Status when Telephoned to Recording Machine October 1980

Final
Issued by:
Guidance Issuing Office
Center for Drug Evaluation and Research

BACKGROUND:

Under Section 503(b) of the Act the dispensing of a prescription drug contrary to a written or oral prescription of a physician is an act which results in the drug being misbranded while held for sale. In some cases a physician may telephone the prescription to a pharmacists' recording machine and questions have arisen as to whether this procedure constitutes an acceptable "oral prescription" under the Act.

POLICY:

The 503(b) requirement is complied with if the pharmacist dispenses a prescription drug as ordered by the physician. The FDA considers a recorded prescription as meeting the requirements of an "oral prescription," as allowed by Section 503(b), if the pharmacist plays back the recording and concludes that the voice he or she hears is that of a physician known to the pharmacist, and there is no obvious reason for suspecting the authenticity of the recorded prescription.

Issued: 10/1/80


Submit Comments

Submit comments on this guidance document electronically via docket ID: FDA-2013-S-0610 - Specific Electronic Submissions Intended For FDA's Dockets Management Staff (i.e., Citizen Petitions, Draft Proposed Guidance Documents, Variances, and other administrative record submissions)

If unable to submit comments online, please mail written comments to:

Dockets Management
Food and Drug Administration
5630 Fishers Lane, Rm 1061
Rockville, MD 20852

All comments should be identified with the title of the guidance.

Back to Top